Highlights The most significant physician-related barriers to starting insulin therapy include the patients’ attitudes and perceptions of insulin therapy . The most important barriers affecting the patient’s decision to start therapy include the impact of treatment on their social life and misperceptions about insulin risks. The majority of physician-related barriers are linked to patient-related barriers. This Journal Watch discusses the study “ Barriers of Doctors and Patients in Starting Insulin for Type 2 Diabetes Mellitus ,” published in Cureus , 2022 .
##Need of the study## Good glycemic control is essential to decelerate the progression of diabetes complications. One of the main causes of poor glycemic control is delayed initiation of insulin therapy. 2 The important factor causing the delay in the initiation of insulin therapy despite the poor glycemic control is clinical…
